Janux Therapeutics, Inc. (JANX)
USD 24.17
(-6.23%)
USD 24.17
(-6.23%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Operating Cash Flow | -50.57 Million | -42.92 Million | -16.97 Million | -4.36 Million | -3.82 Million |
| Net Income | -58.29 Million | -63.05 Million | -32.67 Million | -6.78 Million | -4 Million |
| Depreciation & Amortization | 1.95 Million | 841 Thousand | 113 Thousand | 13 Thousand | 6000.00 |
| Deferred income taxes | -277 Thousand | - | - | - | - |
| Stock-based compensation | 20 Million | 17.2 Million | 6.91 Million | 72 Thousand | 6000.00 |
| Change in working capital | -6.55 Million | 4.27 Million | 8.84 Million | 389 Thousand | -69 Thousand |
| Other non-cash items | -7.41 Million | -2.18 Million | -169 Thousand | 1.94 Million | 233 Thousand |
| Investing Cash Flow | -41.19 Million | 58.26 Million | -340.96 Million | - | - |
| Investments in PPE | -1.85 Million | -6.44 Million | -1.48 Million | - | - |
| Acquisitions | 39.34 Million | -64.71 Million | 339.48 Million | - | - |
| Investment purchases | -317.34 Million | -294.38 Million | -473.62 Million | - | - |
| Sales/Maturities of investments | 278 Million | 359.1 Million | 134.14 Million | - | - |
| Other Investing Activities | -39.34 Million | 64.71 Million | -339.48 Million | - | - |
| Financing Cash Flow | 59.54 Million | 500 Thousand | 386.52 Million | 11.52 Million | 4 Million |
| Debt repayment | - | - | - | -2.5 Million | -4 Million |
| Dividends payments | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - |
| Common Stock Issuance | 56.53 Million | 500 Thousand | 204.16 Million | 9.02 Million | - |
| Other Financing Activities | 3.01 Million | 500 Thousand | 182.35 Million | 5 Million | 4 Million |
| Accounts receivables | - | - | 8 Million | -8 Million | - |
| Accounts payables | 277 Thousand | -294 Thousand | 2.13 Million | 14 Thousand | 4000.00 |
| Inventory | - | - | 831 Thousand | 375 Thousand | - |
| Other working capital | -6.83 Million | 4.57 Million | -2.12 Million | 8 Million | -73 Thousand |
| Cash at beginning of period | 52.24 Million | 36.39 Million | 7.81 Million | 658 Thousand | 486 Thousand |
| Cash at end of period | 20.02 Million | 52.24 Million | 36.39 Million | 7.81 Million | 658 Thousand |
| Capital Expenditure | -1.85 Million | -6.44 Million | -1.48 Million | - | - |
| Effect of forex changes on cash | - | - | - | - | - |
| Net cash flow / Change in cash | -32.22 Million | 15.84 Million | 28.58 Million | 7.15 Million | 172 Thousand |
| Free Cash Flow | -52.42 Million | -49.36 Million | -18.45 Million | -4.36 Million | -3.82 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -5.95 Million | -14.76 Million | -11.75 Million | -58.29 Million | -11.56 Million | -17.5 Million |
| Depreciation & Amortization | 506 Thousand | 532 Thousand | 531 Thousand | 1.95 Million | 500 Thousand | 471 Thousand |
| Deferred income taxes | - | - | - | -277 Thousand | - | - |
| Stock-based compensation | 5.75 Million | 5.62 Million | 4.48 Million | 20 Million | 4.54 Million | 5.5 Million |
| Change in working capital | -7.35 Million | -4.44 Million | -1.09 Million | -6.55 Million | -3.08 Million | -1.67 Million |
| Other non-cash items | 11.47 Million | 5.87 Million | -2.06 Million | -7.41 Million | -2.1 Million | -1.84 Million |
| Investing Cash Flow | -190.88 Million | -113.73 Million | 11.12 Million | -41.19 Million | -61.45 Million | 17.87 Million |
| Investments in PPE | -95 Thousand | -197 Thousand | -515 Thousand | -1.85 Million | -470 Thousand | -580 Thousand |
| Acquisitions | - | - | -11.63 Million | 39.34 Million | 60.98 Million | -18.45 Million |
| Investment purchases | -235.54 Million | -178.53 Million | -33.11 Million | -317.34 Million | -135.98 Million | -76.54 Million |
| Sales/Maturities of investments | 44.75 Million | 65 Million | 44.75 Million | 278 Million | 75 Million | 95 Million |
| Other Investing Activities | -190.79 Million | -113.53 Million | 11.63 Million | -39.34 Million | -60.98 Million | 18.45 Million |
| Financing Cash Flow | 2.76 Million | 322.17 Million | 831 Thousand | 59.54 Million | 56.6 Million | 528 Thousand |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 2.76 Million | 322.17 Million | 831 Thousand | 56.53 Million | 56.6 Million | 528 Thousand |
| Other Financing Activities | 2.76 Million | 322.17 Million | 831 Thousand | 3.01 Million | 56.6 Million | 528 Thousand |
| Accounts receivables | -6.98 Million | -519 Thousand | - | - | - | 750 Thousand |
| Accounts payables | -694 Thousand | -456 Thousand | 327 Thousand | 277 Thousand | 228 Thousand | -171 Thousand |
| Inventory | - | - | 750 Thousand | - | - | -750 Thousand |
| Other working capital | 323 Thousand | -3.47 Million | -1.42 Million | -6.83 Million | -3.3 Million | -1.5 Million |
| Cash at beginning of period | 212.8 Million | 19.2 Million | 17.96 Million | 52.24 Million | 34.51 Million | 31.17 Million |
| Cash at end of period | 14.66 Million | 212.8 Million | 20.02 Million | 20.02 Million | 17.96 Million | 34.51 Million |
| Capital Expenditure | -95 Thousand | -197 Thousand | -515 Thousand | -1.85 Million | -470 Thousand | -580 Thousand |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -198.14 Million | 193.59 Million | 2.05 Million | -32.22 Million | -16.55 Million | 3.34 Million |
| Free Cash Flow | -10.11 Million | -15.03 Million | -10.41 Million | -52.42 Million | -12.17 Million | -15.63 Million |
LORDSCHLO
PASUSPG
PLFF
MSSV
JOBS
SCCO